Huge Buyout Highlights 4 Deutsche Bank Biotech Focus Stocks
In a new report, Deutsche Bank acknowledges that while the industry has shown recent weakness, now may be just the right time to add biotech stocks.
In a new report, Deutsche Bank acknowledges that while the industry has shown recent weakness, now may be just the right time to add biotech stocks.
The higher the market goes, the harder it is for investors to know what to do. One good strategy is to always buy stocks that are the highest conviction picks at a Wall Street…
In a new report, SunTrust Robinson Humphrey concedes that its recent "range bound" call on oil might be in jeopardy, in part due to the plunging rig count.
It has now been six years since the depths of the Great Recession and the ensuing stock market sell-off. We have not had a 10% correction in the markets in over three years.
The demand is huge for data, streaming video and audio, you name it. A new research report from RBC points to some of the top companies in the firm's coverage universe.
Investors may be pondering whether it is time to "sell in May and go away," but consumer discretionary stocks have done well so far this year.
The technology team at UBS like three IT services stocks as a solid tech plays with lower potential volatility.
In a new report, the analysts at Stifel are very positive on two companies leading the charge against antibiotic-resistant "super bugs."
The age of software in this country is changing, and changing rapidly. New companies are jumping into the forefront, and those are the companies Wall Street is starting to focus on.
With a week that saw the end of April and a ton of volatility, we also saw some big insider selling hit the tape.
The very up and down stock market is poised to wind up the first-quarter earnings reports. That also means that insider activity will start to heat up.
Like it or not, the Federal Reserve will be raising interest rates. Buying shares in stocks that will raise dividends may help match any rate increases the Fed has planned.
If Salesforce.com is acquired, there is every reason to think that these five companies could also get a strong look.
Recently, biotech stocks have been getting stung pretty good, and now may be a good time to look at companies with pending catalysts.
JPMorgan sees the market for the top high-yield business development companies (BDCs) remaining smooth, as first-quarter results should be solid.
In a new report, Stifel sees two biotech stocks with near-term catalysts that could make takeover candidates soon.
It can take time for a stock that misses earnings estimates or lowers guidance to rebound. Deutsche Bank says patient investors may came out just fine sticking with these three stocks that absolutely got…
If there is one industry has had its fair share of rules and regulations since the Great Recession and subsequent market debacle of 2008, it is the financial services industry.
The analysts at Cowen have started coverage of oil exploration and production stocks, and these three stocks are the top picks.
With April coming to a close on Thursday, it is time for yet another rebalancing of some of the biggest indexes on Wall Street.